Med BioGene Inc. (MBI) - Medical Equipment - Deals and Alliances Profile

Date: July 21, 2016
Pages: 28
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M73A33E5872EN
Leaflet:

Download PDF Leaflet

Med BioGene Inc. (MBI) - Medical Equipment - Deals and Alliances Profile
Summary

Med BioGene Inc. (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. The company’s lead test under development, GeneFx Lung, formerly LungExpress Dx, is a proprietary gene expression based test. Its GeneFx Lung test is used to identify patients with early-stage non-small-cell lung cancer (NSCLC) and determine whether they are at higher or lower risk of mortality following the surgical removal of their tumor. The GeneFx Lung test is also expected to provide informed and personalized treatment decisions that assist in selecting the patients for adjuvant chemotherapy. Med BioGene is headquartered in Vancouver, British Columbia, Canada.

Med BioGene Inc. (MBI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Med BioGene Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deal Details
Partnerships
Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics
Respira Health Announces Licensing Agreement With Med BioGene
Equity Offering
Med BioGene to Raise USD0.2 Million in Private Placement of Units
Med BioGene Completes Private Placement Of US$0.22 Million
Med BioGene Withdraws Public Offering Of Common Stock For US$28 Million
Acquisition
Med BioGene Announces The Sale Of The Company
Med BioGene Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Corporate Communications
Mar 02, 2015: Med BioGene Announces Appointment of New Director
Other Significant Developments
Jun 01, 2015: Med BioGene Provides Update
Feb 03, 2015: MBI Provides Shareholder Update
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Med BioGene Inc., Medical Equipment, Key Facts, 2015
Med BioGene Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Med BioGene Inc., Deals By Market, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics
Respira Health Announces Licensing Agreement With Med BioGene
Med BioGene to Raise USD0.2 Million in Private Placement of Units
Med BioGene Completes Private Placement Of US$0.22 Million
Med BioGene Withdraws Public Offering Of Common Stock For US$28 Million
Med BioGene Announces The Sale Of The Company
Med BioGene Inc., Key Competitors
Med BioGene Inc., Key Employees
Med BioGene Inc., Subsidiaries

LIST OF FIGURES

Med BioGene Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Med BioGene Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Med BioGene Inc. (MBI) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: